Medical & Biological Laboratories Co., Ltd.

Japon


Commandez votre montre hebdomadaire Medical & Biological Laboratories Co., Ltd.
Quantité totale PI 55
Quantité totale incluant filiales 59 (+ 4 pour les filiales)
Rang # Quantité totale PI 25 446
Note d'activité PI 1,9/5.0    11
Rang # Activité PI 81 188
Activité incl filiales 1,7/5.0    13
Classe Nice dominante Produits chimiques destinés à l'...

Brevets

Marques

16 4
1 0
28 4
2
 
Dernier brevet 2024 - Peptide exchange system and method
Premier brevet 1992 - Chicken-specific immunoglobulin ...
Dernière marque 2022 - MBL
Première marque 2002 - MBL

Filiales

1 subsidiaries with IP (4 patents, 0 trademarks)

 S'inscrire grtuitement pour accéder à la liste des filiales

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention Peptide exchange system and method. The methods disclosed in the present disclosure allow quanti...
2023 Invention Protein collection determination system, protein collection determination method, and recording m...
2022 P/S Chemical reagents for medical purposes in the fields of cancer, cardiology, autoimmunity and immu...
Invention T cell epitope peptide derived from sars-cov-2. An antigen peptide which contains at least five c...
Invention Anti-her2 antibody and pharmaceutical composition containing same. Provided is a non-cardiotoxic ...
2020 Invention Mhc class ii molecule-based peptide exchange system and method. The present disclosure relates t...
P/S Reagents for use in medical genetic testing; diagnostic reagents for medical use; reagents for m...
Invention Prognosis prediction method of idiopathic pulmonary fibrosis. A method for determining a prognos...
Invention Prognosis prediction method of idiopathic pulmonary fibrosis. This method for determining the pro...
2018 Invention Method using fluorescent proteins for determining interaction between proteins. This method deter...
Invention Method for purifying mesenchymal stem cells to improve transplantation efficiency. A method for p...
2017 P/S Chemical substances for analyses in laboratories, other than for medical or veterinary purposes; ...
P/S Chemical substances for analyses in laboratories, other than for medical or veterinary purposes;...
Invention Peptide exchange system and method. The methods and kits disclosed in the present disclosure allo...
2016 Invention Hla-a11 restrictive cytotoxic t cell epitope peptide. The objective of the present invention is t...
Invention Method for detecting protein-protein interaction. determining an interaction between the first pr...
2015 Invention Tumor antigen peptide. The object is to provide a tumor antigen peptide that is specifically pres...
Invention Tumor antigen peptides. The purpose of the present invention is to provide: a tumor antigen pepti...
Invention Method for judging protein interaction.  A method for judging the interaction between a first pro...
Invention Antibody having infection-inhibiting activity against hepatitis c virus. An anti-hepatitis C vir...
Invention Antibody having infection-inhibiting activity against hepatitis c virus.  The present invention p...
2014 Invention Antinuclear antibody image analysis system, antinuclear antibody image analysis method, and antin...
Invention Antibody having broad neutralization activity against group 1 influenza a viruses. From PBMCs of...
Invention Antibody having broad neutralizing activity in group 1 influenza a virus.  From PBMCs originating...
Invention Functional monoclonal antibody against heparin-binding epidermal growth factor-like growth factor...
Invention Antibody against human nrg1 protein. An object is to provide an antibody capable of specifically ...
Invention Antibodies to human nrg1 protein. The present invention addresses the problem of providing antibo...
2013 Invention Method for preparation of antigen-specific cytotoxic t lymphocytes. The invention is intended to...
Invention T cell receptor and uses thereof. A method has been developed to efficiently proliferate and cult...
Invention Monoclonal antibody against human midkine. A monoclonal antibody, which recognizes at least two a...
Invention Monoclonal antibody against human midkine. It is found that a monoclonal antibody capable of reco...
Invention Anti-cxadr antibody. An object is to find a target molecule effective for cancer treatments and t...
Invention Anti-cxadr antibody.  In order to provide an antibody that can detect a target molecules useful f...
2012 Invention Method for detecting protein-protein interaction. A method for detecting interaction between a fi...
Invention Molecular marker for the early detection of malignant pleural mesothelioma and the methods of its...
Invention Molecular marker for early indentification of pleural mesothelioma patients, and expression analy...
Invention Monoclonal antibody for human telomerase reverse transcriptase. A monoclonal antibody which binds...
2011 Invention Methods and composition for testing, preventing, and treating aspergillus fumigatus infection. A...
Invention Method for testing for, preventing, and treating infectious disease aspergillus fumigatus; and co...
Invention Fluorescent protein. Montipora. sp.
Invention Antibody being capable of binding to transforming growth factor alpha and having growth-suppressi...
Invention Antibody capable of binding to transforming growth factor alpha and having antiproliferative acti...
Invention Fluorescent protein and chromoprotein. Actinia equine.
Invention Esophageal cancer marker. As a result of immunohistochemical staining of human cancer pathologica...
2010 Invention Fluorescent protein and chromoprotein. Scolymia vitiensis, which have certain fluorescent property.
P/S Pharmaceutical, veterinary and sanitary preparations; reagents for medical use; reagents for dia...
2009 Invention Kit for preparation of antigen-specific cytotoxic lymphocytes. The invention is intended to furt...
Invention Anti-human clcp1 antibody and use thereof. The present invention provides novel antibodies that r...
Invention Diagnostic kit for solid cancer and medicament for solid cancer therapy. The present invention p...
Invention Composition for neutralizing botulinus toxin type-a, and human anti-botulinus toxin type-a antibo...
2007 Invention Antibody having enhanced adcc activity and method for production thereof. Disclosed is an antibo...
P/S Pharmaceutical, veterinary and sanitary preparations; medicines for human purposes; drugs for me...
2006 P/S Chemical reagents other than for medical purposes, reagents for biochemical basic research purpos...
2004 P/S Proteins and protein based kits comprised of buffers, controls, substrates and other chemical rea...
2003 Invention Antibody library. An antibody library is prepared by selecting a light chain variable region capa...
2002 P/S Proteins and protein based kits comprised of buffers, controls, substrates, and other chemical re...